ANGELA CRAIG: Open Payments
NPI 1902288095 · DERIDDER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 23 payments from 11 companies in 2025. Trend: 2023 $390 · 2024 $496 · 2025 $634
Food & beverage: $522Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $150 |
| Janssen Pharmaceuticals, Inc | 4 | $95 |
| Alkermes, Inc. | 4 | $86 |
| Becton, Dickinson and Company | 1 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| ABBVIE INC. | 2 | $39 |
| TerSera Therapeutics LLC | 1 | $36 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: SPRAVATO, ARISTADA, HemoSphere, CAPLYTA, VRAYLAR, Zoladex, Auvelity, COBENFY.
Industry payments across LA — which companies pay providers there.
